Your browser doesn't support javascript.
loading
The Effects of Treatment on Peripheral Blood Immune Cell Profile in Pancreatic Ductal Adenocarcinoma (PDAC).
Tulyte, Skaiste; Characiejus, Dainius; Matuzeviciene, Reda; Janiulioniene, Ausra; Radzevicius, Mantas; Zvirblis, Tadas; Sileikis, Audrius.
Afiliação
  • Tulyte S; Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania; skaiste.tulyte@santa.lt.
  • Characiejus D; Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
  • Matuzeviciene R; Department of Pathology, Forensic Medicine and Pharmacology, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
  • Janiulioniene A; Department of Physiology, Biochemistry, Microbiology and Laboratory Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
  • Radzevicius M; Department of Physiology, Biochemistry, Microbiology and Laboratory Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
  • Zvirblis T; Department of Physiology, Biochemistry, Microbiology and Laboratory Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
  • Sileikis A; Department of Mechanical and Material Engineering, Vilnius Gediminas Technical University, Vilnius, Lithuania.
Anticancer Res ; 42(6): 3067-3073, 2022 06.
Article em En | MEDLINE | ID: mdl-35641268

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article